Ganciclovir (Cymevene) is indicated for the treatment of cytomegalovirus (CMV) disease in immunocompromised individuals ≥12 years of age.
Ganciclovir (Cymevene) is indicated for the prevention of CMV disease using pre-emptive therapy in patients with drug-induced immunosuppression following organ transplantation or cancer chemotherapy in patients ≥12 years of age.
Ganciclovir (Cymevene) is also indicated for the prevention of CMV disease using universal prophylaxis in patients with drug-induced immunosuppression following organ transplantation or cancer chemotherapy from birth.
Other Services
Country
Account